AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 64 min read$REAX

The Real Brokerage’s (NASDAQ:REAX) Q2 CY2026 Sales Top Estimates

The Real Brokerage (NASDAQ:REAX) reported Q2 CY2026 revenue of $700.6 million, up 29.6% year on year and 7.1% above Wall Street estimates, according to the company. GAAP EPS was -$0.03, below analysts’ consensus. The company’s operating margin was -1%. Analysts expect revenue growth of 13.2% over the next 12 months.

Original reporting
financialcontent.com
Published Aug 6, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 2:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
The Real Brokerage’s (NASDAQ:REAX) Q2 CY2026 Sales Top Estimates — source image
Source · financialcontent.com
Decision brief

The 30-second read

$REAXNeutralMed
01

Why it matters

Traders can update expectations for growth and profitability trajectory based on the reported revenue beat, GAAP loss per share versus consensus, and the EPS miss alongside negative operating margin.

02

Market read

A Q2 revenue beat with a same-day stock pop is tempered by an EPS miss and negative operating margin, keeping the growth-versus-profitability debate active.

03

What to watch

The article highlights decelerating analyst revenue growth (13.2% next 12 months) and a critical path to break-even, which may matter more than the single-quarter beat.

Relevance 7/10Novelty 7/10Timing: post-Q2 results, same-day reaction reported

Background

The Real Brokerage is a tech-driven real estate brokerage firm; this article summarizes its Q2 CY2026 results versus Wall Street expectations.

Company-level read

Ticker impact

$REAXNeutralMedium confidence
Context

The Real Brokerage reported Q2 CY2026 revenue of $700.6M, up 29.6% YoY, beating estimates by 7.1%, while EPS was -$0.03.

Expected impact

Near-term volatility likely, with upside bias from the revenue beat offset by continued loss-making signals.

Evidence & confidence

The article provides a concrete earnings snapshot: revenue beat and GAAP loss per share better than consensus, but EPS missed and operating margin was -1%, implying investors will weigh growth versus profitability.

Market effects

Sector

Signals ongoing growth in real-estate tech brokerage demand, but profitability remains a key constraint for the business model.

Regional

No specific regional spillover described beyond the company’s Toronto founding.

Global

No direct global macro or cross-border catalyst mentioned.

Counterpoint

What could challenge this read

The revenue beat may reflect temporary factors, while the persistent negative operating margin suggests the market should not extrapolate profitability improvement too quickly.

Key entities

  • company
    The Real Brokerage

    NASDAQ-listed real estate technology brokerage reporting Q2 CY2026 revenue and EPS results.

  • market_reference
    Wall Street estimates

    Consensus benchmarks cited for revenue and EPS comparisons.

Read at source← All news

Also covered by

1 outlet

Related articles

AUG 6
$REAXMedAI 8/10

The Real Brokerage Inc. Announces Second Quarter 2026 Financial Results

The Real Brokerage Inc. (NASDAQ: REAX) reported Q2 2026 results for the quarter ended June 30, 2026. Revenue rose 30% to $700.6 million and Adjusted EBITDA increased 38% to $27.6 million. GAAP net loss was $8.0 million. The company said it has $86.6 million cash with no debt and plans to acquire RE/MAX, with a securityholder vote set for Aug. 14, 2026.

leaderpost.com4 min
JUL 14
$REAXMedAI 8/10

The Real Brokerage (REAX) Stock Trades Up, Here Is Why

The Real Brokerage (NASDAQ: REAX) shares rose about 4.5% after the US Department of Justice granted early termination of the HSR waiting period for its proposed merger with RE/MAX Holdings. The deal still needs shareholder approval, with votes set for Aug. 14. After the open, REAX traded around $2.15, up 3.6%.

financialcontent.com5 min
AUG 8
$MATVMed

Mativ Q2 Earnings Call Highlights

Mativ (NYSE:MATV) reported Q2 adjusted EBITDA of $50 million, up more than 18%, and segment margin up 210 bps to 15.3% as pricing offset inflation. Healthcare operations at its Knoxville facility normalized after an outage. Net debt fell to $908 million and net leverage improved to 3.8x. A Menasha, Wisconsin tornado is expected to cut Q3 sales by $20M to $25M.

yahoo.com6 min
AUG 8
$MAINMed

Main Street Capital Q2 Earnings Call Highlights

Main Street Capital (NYSE:MAIN) reported Q2 results on an earnings call. Total investment income was $149.6M (+3.9% YoY, +6.8% QoQ). DNII before taxes was $1.08/share; CFO expects at least $0.97/share in Q3. The board declared a $0.30 supplemental dividend and regular monthly dividends of $0.265/share. MAIN invested about $100M in lower middle market deals and $239M in private loans.

yahoo.com6 min
AUG 8
$LTMMedAI 8/10

LATAM Airlines Group Q2 Earnings Call Highlights

LATAM Airlines Group reported Q2 net income of $125 million and adjusted operating cash flow of $476 million, with nearly $150 million positive cash change before dividends. The company said premium revenue was 29% of passenger revenue and LATAM Pass generated over 67% of passenger revenue. It reinstated 2026 guidance: revenue $17.3B to $17.7B and adjusted EBITDA $4.1B to $4.4B, plus 9% to 10% capacity growth.

yahoo.com6 min
AUG 8
$MAGNMed

Magnera Q3 Earnings Call Highlights

Magnera (NYSE:MAGN) reported Q3 updates on infrastructure and filtration-related sales, with Americas revenue essentially flat year over year. Adjusted EBITDA rose 16% to $71 million in the Americas. The company reaffirmed full-year free cash flow of about $90M to $110M, but expects full-year adjusted EBITDA toward the low end of its prior range, citing inflation and macro uncertainty.

yahoo.com6 min